Molecular Endocrinology, Vol 6, 409-415, Copyright © 1992 by Endocrine Society

ARTICLES

Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance

S Zoppi, M Marcelli, JP Deslypere, JE Griffin, JD Wilson and MJ McPhaul
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8857.

In some subjects with genetic and endocrine evidence of androgen resistance, no defect is demonstrable in the binding of androgen to its receptor in cultured genital skin fibroblasts. We have defined the molecular defect in the androgen receptor in four unrelated subjects in this category (termed receptor positive) with the phenotype of compete or incomplete testicular feminization. In these patients we detected amino acid substitutions in either exon 2 or exon 3, which encodes the DNA-binding domain of the androgen receptor. In one patient with incomplete testicular feminization, two separate mutations were present in exon 3. Introduction of these amino acid substitutions into the androgen receptor-coding segment leads to the expression of receptor proteins that bind ligand in a normal fashion but do not activate the transcription of the androgen-responsive mouse mammary tumor virus promoter. Mobility shift assays using androgen receptor fusion proteins produced in E. coli indicate that these mutations impair binding of the receptor to specific DNA sequences. In the subject with incomplete testicular feminization, a Ser-Gly substitution at amino acid residue 595 is able to partially restore DNA-binding activity to a mutant receptor protein that carries an Arg-Pro substitution at position 615. These findings indicate that mutations in amino acid residues crucial to the binding of the androgen receptor to target DNA sequences are a common cause of receptor-binding positive androgen resistance and that variable impairment of DNA binding can lead to distinctive phenotypes.

This article has been cited by other articles:

				M. L. Cutress, H. C. Whitaker, I. G. Mills, M. Stewart, and D. E. Neal Structural basis for the nuclear import of the human androgen receptor J. Cell Sci., April 1, 2008; 121(7): 957 - 968. [Abstract] [Full Text] [PDF]

				K.A. Walters, C.M. Allan, and D.J. Handelsman Androgen Actions and the Ovary Biol Reprod, March 1, 2008; 78(3): 380 - 389. [Abstract] [Full Text] [PDF]

				K. A. Walters, C. M. Allan, M. Jimenez, P. R. Lim, R. A. Davey, J. D. Zajac, P. Illingworth, and D. J. Handelsman Female Mice Haploinsufficient for an Inactivated Androgen Receptor (AR) Exhibit Age-Dependent Defects That Resemble the AR Null Phenotype of Dysfunctional Late Follicle Development, Ovulation, and Fertility Endocrinology, August 1, 2007; 148(8): 3674 - 3684. [Abstract] [Full Text] [PDF]

				M. Lanzino, F. De Amicis, M. J. McPhaul, S. Marsico, M. L. Panno, and S. Ando Endogenous Coactivator ARA70 Interacts with Estrogen Receptor {alpha} (ER{alpha}) and Modulates the Functional ER{alpha}/Androgen Receptor Interplay in MCF-7 Cells J. Biol. Chem., May 27, 2005; 280(21): 20421 - 20430. [Abstract] [Full Text] [PDF]

				G. Pandini, R. Mineo, F. Frasca, C. T. Roberts Jr., M. Marcelli, R. Vigneri, and A. Belfiore Androgens Up-regulate the Insulin-like Growth Factor-I Receptor in Prostate Cancer Cells Cancer Res., March 1, 2005; 65(5): 1849 - 1857. [Abstract] [Full Text] [PDF]

				E. Unni, S. Sun, B. Nan, M. J. McPhaul, B. Cheskis, M. A. Mancini, and M. Marcelli Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence Cancer Res., October 1, 2004; 64(19): 7156 - 7168. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor (AR) Coregulators: An Overview Endocr. Rev., April 1, 2002; 23(2): 175 - 200. [Abstract] [Full Text] [PDF]

				M. J. McPhaul Molecular Defects of the Androgen Receptor Recent Prog. Horm. Res., January 1, 2002; 57(1): 181 - 194. [Abstract] [Full Text] [PDF]

				D. Nguyen, S. V. Steinberg, E. Rouault, S. Chagnon, B. Gottlieb, L. Pinsky, M. Trifiro, and S. Mader A G577R Mutation in the Human AR P Box Results in Selective Decreases in DNA Binding and in Partial Androgen Insensitivity Syndrome Mol. Endocrinol., October 1, 2001; 15(10): 1790 - 1802. [Abstract] [Full Text] [PDF]

				F. Andriani, B. Nan, J. Yu, X. Li, N. L. Weigel, M. J. McPhaul, S. Kasper, S. Kagawa, B. Fang, R. J. Matusik, et al. Use of the Probasin Promoter ARR2PB to Express Bax in Androgen Receptor-Positive Prostate Cancer Cells J Natl Cancer Inst, September 5, 2001; 93(17): 1314 - 1324. [Abstract] [Full Text] [PDF]

				M. Marcelli, M. Ittmann, S. Mariani, R. Sutherland, R. Nigam, L. Murthy, Y. Zhao, D. DiConcini, E. Puxeddu, A. Esen, et al. Androgen Receptor Mutations in Prostate Cancer Cancer Res., February 1, 2000; 60(4): 944 - 949. [Abstract] [Full Text]

				M. J. McPhaul and J. E. Griffin Male Pseudohermaphroditism Caused by Mutations of the Human Androgen Receptor J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3435 - 3441. [Full Text] [PDF]

				P. Aarnisalo, H. Santti, H. Poukka, J. J. Palvimo, and O. A. Jänne Transcription Activating and Repressing Functions of the Androgen Receptor Are Differentially Influenced by Mutations in the Deoxyribonucleic Acid-Binding Domain Endocrinology, July 1, 1999; 140(7): 3097 - 3105. [Abstract] [Full Text]

				J. Lu and M. Danielsen Differential Regulation of Androgen and Glucocorticoid Receptors by Retinoblastoma Protein J. Biol. Chem., November 20, 1998; 273(47): 31528 - 31533. [Abstract] [Full Text] [PDF]

				L. V. Nazareth and N. L. Weigel Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway J. Biol. Chem., August 16, 1996; 271(33): 19900 - 19907. [Abstract] [Full Text] [PDF]